Research

Molecular Pharmacology and Experimental Therapeutics (MPET)

Search publications

Publications

  • Minuesa G, Albert C, Pastor-Anglada M, Martinez-Picado J and Koepsell H.

    Response to Tenofovir Disoproxil Fumarate Is Not an Inhibitor of Human Organic Cation Transporter 1.

    J PHARMACOL EXP THER . 360(2): 343-345. Number of citations: 5

    [doi:10.1124/jpet.116.239004]

  • Grañé-Boladeras N, Spring CM, Hanna WJ, Pastor-Anglada M and Coe IR.

    Novel nuclear hENT2 isoforms regulate cell cycle progression via controlling nucleoside transport and nuclear reservoir.

    CELLULAR AND MOLECULAR LIFE SCIENCES . 73(23): 4559-4575. Number of citations: 18

    [doi:10.1007/s00018-016-2288-9]

  • Grañé-Boladeras N, Perez-Torras S, Lozano JJ, Romero MR, Mazo A, Marín JJ and Pastor-Anglada M.

    Pharmacogenomic analyzis of the responsiveness of gastrointestinal tumor cell lines to drug therapy: A transportome approach.

    PHARMACOLOGICAL RESEARCH . 113(Pt A): 364-375. Number of citations: 4

    [doi:10.1016/j.phrs.2016.09.007]

  • Minuesa G, Arimany-Nardi C, Erkizia I, Cedeño S, Moltó J, Clotet B, Pastor-Anglada M and Martinez-Picado J.

    P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 71(10): 2782-2792. Number of citations: 21

    [doi:10.1093/jac/dkw215]

  • Perez-Torras S, Iglesias I, Llopis M, Lozano JJ, Antolín M, Guarner F and Pastor-Anglada M.

    Transportome Profiling Identifies Profound Alterations in Crohn's Disease Partially Restored by Commensal Bacteria

    JOURNAL OF CROHNS & COLITIS . 10(7): 850-859. Number of citations: 20

    [doi:10.1093/ecco-jcc/jjw042]

  • Fernández-Calotti P, Casulleras-Gras O, Antolin M, Guarner F and Pastor-Anglada M.

    Galectin-4 interacts with the drug transporter human concentrative nucleoside transporter 3 to regulate its function

    FASEB JOURNAL . 30(2): 544-554. Number of citations: 11

    [doi:10.1096/fj.15-272773]

  • Kretschmar C, Oyarzún C, Villablanca C, Jaramillo C, Alarcón S, Perez G, Díaz-Encarnación MM, Pastor-Anglada M, Garrido W, Quezada C and San Martín R.

    Reduced Adenosine Uptake and Its Contribution to Signaling that Mediates Profibrotic Activation in Renal Tubular Epithelial Cells: Implication in Diabetic Nephropathy

    PLoS One . 11(1): . Number of citations: 30

    [doi:10.1371/journal.pone.0147430]

  • Veyhl-Wichmann M, Friedrich A, Vernaleken A, Singh S, Kipp H, Gorboulev V, Keller T, Chintalapati C, Pipkorn R, Pastor-Anglada M, Groll J and Koepsell H.

    Phosphorylation of RS1 (RSC1A1) Steers Inhibition of Different Exocytotic Pathways for Glucose Transporter SGLT1 and Nucleoside Transporter CNT1, and an RS1-Derived Peptide Inhibits Glucose Absorption

    MOLECULAR PHARMACOLOGY . 89(1): 118-132. Number of citations: 23

    [doi:10.1124/mol.115.101162]

  • Arimany-Nardi C, Minuesa G, Keller T, Erkizia I, Koepsell H, Martinez-Picado J and Pastor-Anglada M.

    Role of Human Organic Cation Transporter 1 (hOCT1) Polymorphisms in Lamivudine (3TC) Uptake and Drug-Drug Interactions.

    FRONTIERS IN PHARMACOLOGY . 7: 175-175. Number of citations: 16

    [doi:10.3389/fphar.2016.00175]

  • Arimany-Nardi C, Koepsell H and Pastor-Anglada M.

    Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions

    PHARMACOGENOMICS JOURNAL . 15(6): 473-487. Number of citations: 29

    [doi:10.1038/tpj.2015.78]